| Product Code: ETC6412008 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bhutan Antimicrobial Resistance Market Overview |
3.1 Bhutan Country Macro Economic Indicators |
3.2 Bhutan Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Bhutan Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Bhutan Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Bhutan Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Bhutan Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Bhutan Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Bhutan Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Bhutan Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Bhutan |
4.2.2 Growing awareness about the misuse of antibiotics |
4.2.3 Government initiatives to combat antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Bhutan |
4.3.2 Lack of stringent regulations on the use of antibiotics |
4.3.3 Limited resources and infrastructure for implementing antimicrobial stewardship programs |
5 Bhutan Antimicrobial Resistance Market Trends |
6 Bhutan Antimicrobial Resistance Market, By Types |
6.1 Bhutan Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Bhutan Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Bhutan Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Bhutan Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Bhutan Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Bhutan Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Bhutan Antimicrobial Resistance Market Export to Major Countries |
7.2 Bhutan Antimicrobial Resistance Market Imports from Major Countries |
8 Bhutan Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities with antimicrobial stewardship programs in place |
8.2 Rate of adherence to guidelines for antibiotic prescription |
8.3 Number of educational campaigns and workshops conducted on antimicrobial resistance in Bhutan |
9 Bhutan Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Bhutan Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Bhutan Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Bhutan Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Bhutan Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Bhutan Antimicrobial Resistance Market - Competitive Landscape |
10.1 Bhutan Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Bhutan Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here